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The skeletal dysplasias are a large, heterogeneous group
of genetic conditions characterized by abnormal devel-
opment, growth and maintenance of the elements
(bones) comprised in the human skeleton [1]. In the
2010 revision of nosology and classification of genetic
skeletal disorders, 456 conditions were included and
placed in 40 groups defined by molecular, biochemical,
and/or radiographic criteria. Of these conditions, 316
were associated with mutations in one or more of 226
different genes [2], and are present in about 5% of chil-
dren with birth defects [3]. About 100 skeletal dysplasias
have prenatal onset [4] with ultrasound findings particu-
larly in the second trimester [5]. The first step for an
accurate diagnosis is a detailed clinical-radiographic eva-
luation [4]. In fact, because of clinical and genetic het-
erogeneity of these diseases, with partial clinical overlap,
diagnosis is difficult with a consequent delay in specific
follow-up and management.
Clinical and molecular characterization of a large
patients series is the first step that leads to an improve-
ment in knowledge about natural history, epidemiology
and pathogenesis of this disease. These advancements
are promoted by expertise centres where patients can be
followed-up by multidisciplinary teams, required for
syndromic nature or different skeletal segments involve-
ment in the most of cases. To improve skeletal disease
knowledge, often lacking, it is essential to analyze and
integrate available clinical and genetic data; to this
purpose, the design and development of disease-specific
registries [5] is essential, as well as the presence of a
Biobank for the collection of biospecimens.
Our experience as Reference Centre for Skeletal Dyspla-
sias led us to activate specific diseases registries, as Multi-
ple Osteochondromas Registry (REM), using an HL7
compliant platform, GePhCARD (Genotype-Phenotype
Correlation, Analyses and Research Database) that can
encompass clinical, genetic, genealogical and imaging data
[6]. This web-application is protected by an authentication
system, a relief tool articulated in multilevel access profile
for data legal protection and patients’ privacy. GePhCARD
will be soon interfaced with BIOGEN (Genetic Biobank)
and together will contribute to improve diagnosis and clin-
ical and molecular characterization of rare diseases, allow-
ing to collect high quality biological materials of skeletal
dysplasias patients [7].
In this presentation we focus on our experience on a
specific skeletal disease, Hereditary Multiple Osteochon-
dromas (MO), and demonstrate how a systematic integra-
tion of clinical and molecular data is focal to increase the
knowledge on MO natural history and epidemiology [8],
contributing also to define personalized and appropriate
follow-up and to hypothesize research studies.
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